AxioMed Spine Stock

AxioMed Spine develops products that restore the spinal function of patients with degenerative spine diseases.

Sign up today and learn more about AxioMed Spine Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About AxioMed Spine Stock

AxioMed Spine Corporation, located in Cleveland, Ohio, was formed in 2001 to develop products with a goal of restoring spinal function to patients with degenerative spine disease; thus advancing the standard of care beyond fusion and first generation artificial discs. Since its inception, AxioMed has secured over $34M in private equity financing from prestigious venture capitalists. The company´s Freedom® Lumbar Disc has been developed and clinical trials initiated. The company is headed by CEO, Patrick McBrayer, who joined AxioMed in early 2006. Mr. McBrayer along with founder and COO, James Kuras, lead an experienced management and development team with significant history and expertise in spinal implants, including early artificial disc development efforts. Company employment includes professionals with extensive spine and engineering experience. The team is augmented by a Medical Advisory Panel of surgeons from leading spine centers and universities. The company´s headquarters include product development and testing, clinical and regulatory affairs, and manufacturing. AxioMed will leverage its background in lumbar disc replacement with an ongoing development project for the cervical spine.

Funding History

February 2003$2.8M
November 2009$6.4M
July 2010$9.5M
October 2010$15.0M
March 2011$500K
May 2012$5.0M
January 2013$3.6M
April 2014$1.1M


President & CEO & Board of Directors

Patrick McBrayer

Vice President for Clinical and Regulatory Affairs

Neal Defibaugh

Co-Founder & CFO

Aditya Humad

Chief Financial Officer

Jerry Baty

COO & Board of Directors

James Kuras

Founder & CEO

Kingsley R. Chin


EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: